These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3558857

  • 1. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.
    Vaughan Hudson B, Linch DC, Macintyre EA, Bennett MH, MacLennan KA, Vaughan Hudson G, Jelliffe AM.
    J Clin Pathol; 1987 Mar; 40(3):247-50. PubMed ID: 3558857
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Grades of nodular sclerosis (NSI-NSII) in Hodgkin's disease. Are they of independent prognostic value?
    Wijlhuizen TJ, Vrints LW, Jairam R, Breed WP, Wijnen JT, Bosch LJ, Crommelin MA, van Dam FE, de Koning J, Verhagen-Teulings M.
    Cancer; 1989 Mar 15; 63(6):1150-3. PubMed ID: 2917317
    [Abstract] [Full Text] [Related]

  • 6. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease.
    Axdorph U, Porwit-MacDonald A, Grimfors G, Björkholm M.
    Leuk Lymphoma; 2001 Mar 15; 42(5):1055-65. PubMed ID: 11697623
    [Abstract] [Full Text] [Related]

  • 7. [Blood eosinophilia in Hodgkin's disease and radiation therapy (author's transl)].
    Chabasse D, Oriot M, Larra F.
    Sem Hop; 2001 Mar 15; 57(7-8):373-8. PubMed ID: 6261373
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hodgkin's lymphoma presenting as hypereosinophilia syndrome.
    Singh RP, Emmatty JG, Bhama T.
    J Assoc Physicians India; 1984 Jun 15; 32(6):528-9. PubMed ID: 6511735
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcome in Hodgkin's disease: a 20-year cohort of patients.
    Ranaghan L, Markey GM, Morris TC.
    Ulster Med J; 1998 Nov 15; 67(2):91-8. PubMed ID: 9885544
    [Abstract] [Full Text] [Related]

  • 13. Lymphopenia: a bad prognostic factor in Hodgkin's disease.
    Hancock BW, Dunsmore IR, Swan HT.
    Scand J Haematol; 1982 Sep 15; 29(3):193-9. PubMed ID: 7146822
    [Abstract] [Full Text] [Related]

  • 14. Systemic disturbance in Hodgkin's disease and its relation to histopathology and prognosis (BNLI report No. 30).
    Vaughan Hudson B, Maclennan KA, Bennett MH, Easterling MJ, Vaughan Hudson G, Jelliffe AM.
    Clin Radiol; 1987 May 15; 38(3):257-61. PubMed ID: 3581667
    [Abstract] [Full Text] [Related]

  • 15. Marked eosinophilia and eosinophilic pleural effusion in Hodgkin's disease. Report of a case with review of literature.
    Farah MG, Nassar VH, Shahid M.
    J Med Liban; 1973 May 15; 26(5):513-21. PubMed ID: 4781060
    [No Abstract] [Full Text] [Related]

  • 16. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC, Valente G, Kerim S, Navone R, Onesti P, Chiusa L, Resegotti L, Palestro G.
    Haematologica; 1997 May 15; 82(3):281-5. PubMed ID: 9234572
    [Abstract] [Full Text] [Related]

  • 17. An autopsy case of Hodgkin's disease with marked eosinophilia.
    KOIDE O, KOGURE T.
    Acta Pathol Jpn; 1959 Nov 15; 9(Suppl)():1005-12. PubMed ID: 14457864
    [No Abstract] [Full Text] [Related]

  • 18. [Malignant granuloma with lipoid thesaurismosis and importunate regional eosinophilia (cutaneous); clinical and anatomopathological aspects].
    D'ANTUONO G, PIERAGNOLI E, CALICETI G.
    Arch Ital Anat Istol Patol; 1955 Nov 15; 29(5):413-55. PubMed ID: 13303636
    [No Abstract] [Full Text] [Related]

  • 19. IgE, Reed-Sternberg cells, and eosinophilia in Hodgkin's disease.
    Samoszuk M, Ramzi E.
    Leuk Lymphoma; 1993 Mar 15; 9(4-5):315-9. PubMed ID: 8348067
    [Abstract] [Full Text] [Related]

  • 20. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ, Taylor PR, Angus B, Wood K, Lennard AL, Lucraft H, Carey PJ, Stark A, Iqbal A, Haynes A, Russel N, Leonard RC, Culligan D, Conn J, Jackson GH.
    Eur J Haematol Suppl; 2001 Jul 15; 64():28-32. PubMed ID: 11486397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.